Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

What Oregon’s Measure 109 Means for Hopeful Entrepreneurs and Investors

Feb 9 • 6 min read

While entrepreneurs and investors are likely to see Oregon’s Measure 109 as a chance to capitalize on new business opportunities and investments, it’s worth highlighting that this new law is unlikely to lead to a psilocybin gold rush.

Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind

Jan 5 • 10 min read

“The standard of care in mental health is broken and has been for decades.” We were speaking with Yaron Conforti, the CEO and Director of Novamind about the catalyst that led to the creation of the company which is going public today, January 5th 2021. Yaron explained that mental health has been in crisis mode…

Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge

Jan 4 • 3 min read

After gaining 54.66% in the month of November, the Psychedelic Invest Index had a much quieter month in December, finishing with a gain of only 2.23%. On Thursday, December 31, 2020, the index closed at a price of $86.69 and marked the end of what was a historic year for the entire psychedelic sector. Since…

Here’s Where Field Trip Health is Opening Locations Next

Dec 1 • 4 min read

Field Trip Health (FTRP), the psychedelic enhanced therapy company that recently went public on the Canadian Stock Exchange (CSE), has an aggressive strategy to open 75 clinics by 2023. The company has previously opened or announced the intention to open six locations worldwide (Toronto, New York, Los Angeles, Chicago, Oregon, and Amsterdam). On November 30,…

Five Psychedelic Law Firms You Should Have On Your Radar

Nov 13 • 8 min read

The secret is out: Investing in psychedelics may be the next explosive trend for investors looking to enter a new industry with massive social impact. Despite many media outlets comparing psychedelic drugs to cannabis, the reality is that psychedelic medicine is much more likely to follow the “traditional biotech path.” That path includes high barriers…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253